Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.860
-0.010 (-0.26%)
Feb 12, 2026, 2:12 PM EST - Market open
CPIX Employees
Cumberland Pharmaceuticals had 91 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
91
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$453,608
Profits / Employee
-$36,574
Market Cap
57.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 91 | 0 | - |
| Dec 31, 2023 | 91 | 6 | 7.06% |
| Dec 31, 2022 | 85 | 2 | 2.41% |
| Dec 31, 2021 | 83 | -7 | -7.78% |
| Dec 31, 2020 | 90 | -4 | -4.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Alpha Teknova | 173 |
| Assertio Holdings | 58 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 28 |
| Cardiol Therapeutics | 18 |
CPIX News
- 8 days ago - Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program - PRNewsWire
- 2 months ago - CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT - PRNewsWire
- 3 months ago - Cumberland Pharmaceuticals Inc. (CPIX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH - PRNewsWire
- 3 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 4 months ago - CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO - PRNewsWire
- 4 months ago - RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal - PRNewsWire
- 4 months ago - CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - PRNewsWire